Clinical Trials Browser

Phase 1 × Completed × Adalimumab × Clear all

NCT04551352 2022-10-03

A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

Phase 1 Completed

Uveal Melanoma, Melanoma

NCT02912247 2019-03-07

Comparative Clinical Trial to Evaluate Bioequivalency and Safety of Monoclonal Antibody Injection and Adalimumab in Chinese Healthy Volunteers

Phase 1 Completed

Healthy